The Asia-Pacific Radiotherapy Market has accounted for USD 1.1 billion in 2016 and is expected to reach USD 2.4 billion by 2024, growing at a CAGR 10.3% during the forecast period 2017 to 2024.
Cancer is the major cause of death in the world and the number of new patients each year is steadily increasing. The most common form of cancer mortality is by metastasis, where the tumors and cancerous cells spread to organs causing failure. The world is focused upon developing solutions and cure to cancer by destroying primary and secondary tumors that cause metastasis.
The key market players for Asia-Pacific Radiotherapy Market are listed below:-
Varian Medical Systems, Inc.
CIVCO Medical Solutions
Elekta AB
Nanobiotix
Accuray Incorporated
Brainlab AG
Ion Beam Applications SA
R. Bard, Inc.
IsoRay Medical, Inc.
TRF, Nordion, Inc.
RaySearch Laboratories AB
PRECISIS AG
Mevion Medical Systems, Inc.
Mitsubishi Electric Corporation
The market is further segmented into:-
Therapy
Product
Application
Product Type
Geography
The Asia-pacific radiotherapy market is segmented based on therapy, product, application, and geography. Based on the therapy, the radiotherapy market is segmented into external beam radiotherapy, internal beam radiotherapy, and systemic radiation therapy.
Based on the delivery of dose-rate, internal beam therapy is divided into low (LDR) and high-dose-rate (HDR). The LDR segment is expected to account for the largest share of the internal radiotherapy/brachytherapy market, whereas the HDR segment is poised to witness the highest growth.
Based on product type the Asia-Pacific radiotherapy market is segmented into EBRT equipment and IBRT equipment.
The External Beam Radiotherapy (EBRT) products are further segmented into cyberknife, gamma knife, LINAC, Proton Beam (Cyclotron, Synclotron).
The Internal Beam Radiotherapy (IBRT) is segmented into seeds, after leaders and others.
The Asia-Pacific radiotherapy market is also segmented based on indication into cancer of different organs such as brain tumor, spine cancer, lung cancer, liver cancer, breast cancer, prostate cancer, and others.
Based on geography, the Asia-Pacific Radiotherapy market is segmented into 11 geographical regions, such as
China
Japan
India
South Korea
Australia
Thailand
Malaysia
Singapore
Indonesia
Philippines
Covered in this report:-
The report covers the present scenario and the growth prospects of the Asia-Pacific Radiotherapy market for 2017-2021. To calculate the market size, the report considers the revenue generated from the sales of web conferencing and unified communication and collaboration (UC&C) and video conferencing, secondary resources and doing in-depth company share analysis of major 10 players in the market. You can request one free hour of our analyst's time when you purchase this market report. Details are provided within the report.
For More Information, Click On The Link Below:-
Related Reports:-
Contact Us:-
Ken Research
Ankur Gupta, Head Marketing & Communications
+91-9015378249
